• NEBANNER

2021 New Style Portable Reverse Osmosis System - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN

2021 New Style Portable Reverse Osmosis System - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We are convinced that with joint endeavours, the small business between us will bring us mutual benefits. We could assure you products quality and competitive selling price for Ozonation Disinfection, Sodium Hypochlorite Electrolysis, Water Treatment Additives, We can easily offer you by far the most aggressive prices and good quality, because we've been much additional Specialist! So please will not hesitate to call us.
2021 New Style Portable Reverse Osmosis System - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN Detail:

It works by stimulating central presynaptic alpha 2- receptors. Its hypotensive effect is similar to that of nifedipine, a calcium antagonist, and captopril, an ACE inhibitor. For essential hypertension.

This product should adopt the principle of individualized medication. Generally start from the lowest dose, that is, 0.2mg, once a day, taken in the morning. Dosage adjustments should be made at three-week intervals until satisfactory results are obtained. The usual dose is 0.2mg once, twice a day (morning and evening). The maximum dose per time shall not exceed 0.4mg, and the maximum daily dose shall not exceed 0.6mg. For patients with mild or moderate renal insufficiency, the single dose should not exceed 0.2 mg or the daily dose should not exceed 0.4 mg.

This product is an α2-receptor agonist, which is an imidazoline antihypertensive drug. Used for moderate and severe primary and secondary hypertension.

Because it inhibits the secretion and movement of the gastrointestinal tract, it is also suitable for hypertensive patients suffering from ulcer disease. The combination of this medicine and diuretics can significantly improve the efficacy. It is a powerful central antihypertensive drug and a second-line antihypertensive drug. It is mainly administered locally in ophthalmology. This product has the effect of reducing intraocular pressure, and does not affect the pupil and eye adjustment mechanism. It can constrict blood vessels in the eye, reduce the production of aqueous humor, and achieve the effect of reducing intraocular pressure. It starts to take effect 15 minutes after the eye drops and can maintain the effect for about 8 hours.

Standard:EP10
Assay content:97.5-102.0%

Exterior: White or almost while powder
Package: 1kg/bag or as required by customers


Product detail pictures:

2021 New Style Portable Reverse Osmosis System - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN detail pictures


Related Product Guide:

Well-run equipment, expert income workforce, and far better after-sales expert services; We are also a unified large family, anyone stick to the corporate value "unification, dedication, tolerance" for 2021 New Style Portable Reverse Osmosis System - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN , The product will supply to all over the world, such as: Juventus, Durban, Swansea, Hard work to keep making progress, innovation in the industry, make every effort to first-class enterprise. We try our best to build the scientific management model, to learn abundant professional knowledge, to develop advanced production equipment and production process , to create the first-call quality products, reasonable price , high quality of service , quick delivery , to give you create new value .
  • A good manufacturers, we have cooperated twice, good quality and good service attitude.
    5 Stars By Carey from Marseille - 2017.04.18 16:45
    The factory technical staff gave us a lot of good advice in the cooperation process, this is very good, we are very grateful.
    5 Stars By Henry stokeld from Japan - 2018.05.22 12:13
    Write your message here and send it to us